In Vitro Activities of New Triazole Antifungal Agents, Posaconazole and Voriconazole, Against Oral Candida Isolates from Patients Suffering from Denture Stomatitis

[1]  M. Amaral,et al.  Local Treatment of Vulvovaginal Candidosis , 2012, Drugs.

[2]  M. Pascale,et al.  Candida-associated denture stomatitis. , 2011, Medicina oral, patologia oral y cirugia bucal.

[3]  K. Zomorodian,et al.  Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers. , 2011, Medical mycology.

[4]  G. Quindós,et al.  Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates. , 2010, Revista Espanola de Quimioterapia.

[5]  M. Ghannoum,et al.  Antifungal activity of miconazole against recent Candida strains , 2010, Mycoses.

[6]  G. Quindós,et al.  In vitro activity of voriconazole against Mexican oral yeast isolates , 2010, Mycoses.

[7]  A. J. Carrillo-Muñoz,et al.  [Antifungal agents for onychomycoses]. , 2010, Revista iberoamericana de micologia.

[8]  H. Nelis,et al.  Fungicidal activity of miconazole against Candida spp . 1 biofilms 2 3 , 2010 .

[9]  J. Hernández-Molina,et al.  [Antifungal agents for onychomycoses]. , 2010, Revista iberoamericana de micologia.

[10]  R. Cannon,et al.  Antifungal drug resistance of oral fungi , 2010, Odontology.

[11]  P. Mann,et al.  Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species , 2009, Antimicrobial Agents and Chemotherapy.

[12]  G. Quindós,et al.  Isolation of Candida dubliniensis in denture stomatitis. , 2009, Archives of oral biology.

[13]  L. Samaranayake,et al.  Oral mucosal fungal infections. , 2009, Periodontology 2000.

[14]  W. Crielaard,et al.  DEVELOPMENT OF CANDIDA-ASSOCIATED DENTURE STOMATITIS: NEW INSIGHTS , 2008, Journal of applied oral science : revista FOB.

[15]  G. Quindós,et al.  Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. , 2008, International journal of antimicrobial agents.

[16]  G. Calais,et al.  Comparison of the efficacy and safety of miconazole 50‐mg mucoadhesive buccal tablets with miconazole 500‐mg gel in the treatment of oropharyngeal candidiasis , 2008 .

[17]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[18]  M. Amaral,et al.  Local treatment of vulvovaginal candidosis : general and practical considerations. , 2008, Drugs.

[19]  M. Pfaller,et al.  Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program , 2007, Journal of Clinical Microbiology.

[20]  J. Pemán,et al.  Actividad antifúngica in vitro de voriconazol: Nuevos datos después de los primeros años de experiencia clínica , 2007 .

[21]  W. Du,et al.  Miconazole Induces Changes in Actin Cytoskeleton prior to Reactive Oxygen Species Induction in Yeast* , 2007, Journal of Biological Chemistry.

[22]  A. Dongari-Bagtzoglou,et al.  Candida glabrata: an emerging oral opportunistic pathogen. , 2007, Journal of dental research.

[23]  M. Pfaller,et al.  Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods , 2006, Journal of Clinical Microbiology.

[24]  G. Quindós,et al.  Evaluation of the New Chromogenic Medium Candida ID 2 for Isolation and Identification of Candida albicans and Other Medically Important Candida Species , 2006, Journal of Clinical Microbiology.

[25]  D. Loebenberg,et al.  In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts , 2006, Antimicrobial Agents and Chemotherapy.

[26]  I. Hapala,et al.  Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B. , 2005, Biochemical Society transactions.

[27]  A. Davies,et al.  Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer. , 2005, Journal of medical microbiology.

[28]  M. Boogaerts,et al.  The place for itraconazole in treatment. , 2005, The Journal of antimicrobial chemotherapy.

[29]  D. Loebenberg,et al.  Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections. , 2005, The Journal of antimicrobial chemotherapy.

[30]  J. Sobel,et al.  Emerging azole antifungals , 2005, Expert opinion on emerging drugs.

[31]  M. Pfaller,et al.  Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus , 2004, Journal of Clinical Microbiology.

[32]  B. Wickes,et al.  Denture stomatitis: a role for Candida biofilms. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[33]  David W Williams,et al.  Evaluation of the recurrence of denture stomatitis and Candida colonization in a small group of patients who received itraconazole. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[34]  E. Katabira,et al.  Comparative Efficacy of Topical Therapy With a Slow-Release Mucoadhesive Buccal Tablet Containing Miconazole Nitrate Versus Systemic Therapy With Ketoconazole in HIV-Positive Patients With Oropharyngeal Candidiasis , 2004, Journal of acquired immune deficiency syndromes.

[35]  D. Loebenberg,et al.  Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. , 2003, The Journal of antimicrobial chemotherapy.

[36]  J. Cleary,et al.  Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States , 2003, Antimicrobial Agents and Chemotherapy.

[37]  E. Chimenos-Küstner.  [Treatment of oral Candidosis]. , 2003, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.

[38]  D. Stevens,et al.  Antifungal drug resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  P. Rompré,et al.  Reassessing the presence of Candida albicans in denture-related stomatitis. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[40]  N. Tsuji,et al.  Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect , 2002, Antimicrobial Agents and Chemotherapy.

[41]  J. Beijnen,et al.  Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons. , 2002, Pharmacological research.

[42]  R. Pelletier,et al.  Voriconazole and fluconazole susceptibility of Candida isolates. , 2002, Journal of medical microbiology.

[43]  J. Rex,et al.  In Vitro Activity of Nystatin Compared with Those of Liposomal Nystatin, Amphotericin B, and Fluconazole against Clinical Candida Isolates , 2002, Journal of Clinical Microbiology.

[44]  D. Ellis.  Amphotericin B: spectrum and resistance. , 2002, The Journal of antimicrobial chemotherapy.

[45]  G. Quindós,et al.  In Vitro Activity of a New Liposomal Nystatin Formulation Against Opportunistic Fungal Pathogens , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[46]  J. Bagg,et al.  Efficacy of the Cyclodextrin Liquid Preparation of Itraconazole in Treatment of Denture Stomatitis: Comparison with Itraconazole Capsules , 2000, Antimicrobial Agents and Chemotherapy.

[47]  G. Quindós,et al.  In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole. , 1999, The Journal of antimicrobial chemotherapy.

[48]  J. Bagg,et al.  Genetic Typing of Candida albicans Strains Isolated from the Oral Cavity of Patients with Denture Stomatitis before and after Itraconazole Therapy , 1999 .

[49]  A. Bolmström,et al.  Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B. , 1998, Diagnostic microbiology and infectious disease.

[50]  B. C. Webb,et al.  Candida-associated denture stomatitis. Aetiology and management: a review. Part 3. Treatment of oral candidosis. , 1998, Australian dental journal.

[51]  G. Stingl,et al.  A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  F. Dromer,et al.  Antifungal drug resistance in pathogenic fungi. , 1998, Medical mycology.

[53]  S. Bernal,et al.  Response to fluconazole and itraconazole of Candida spp. in denture stomatitis , 1997, Mycoses.

[54]  J. Rex,et al.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates , 1995, Antimicrobial agents and chemotherapy.

[55]  A. Sierra,et al.  In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents , 1994, Mycoses.

[56]  V. Bissell,et al.  Comparative trial of fluconazole and amphotericin in the treatment of denture stomatitis. , 1993, Oral surgery, oral medicine, and oral pathology.

[57]  T. Walsh,et al.  Trichosporon beigelii, an emerging pathogen resistant to amphotericin B , 1990, Journal of clinical microbiology.

[58]  P. Holmstrup,et al.  Fluconazole in the treatment of Candida-associated denture stomatitis , 1988, Antimicrobial Agents and Chemotherapy.

[59]  W. Powderly,et al.  Amphotericin B-resistant yeast infection in severely immunocompromised patients. , 1988, The American journal of medicine.

[60]  C. Nord,et al.  Yeast colonization in the oral cavity and feces in patients with denture stomatitis. , 1979, Acta odontologica Scandinavica.